Welcome to our dedicated page for Align Technology news (Ticker: ALGN), a resource for investors and traders seeking the latest updates and insights on Align Technology stock.
Align Technology Inc. (NASDAQ: ALGN) is a prominent global medical device company known for designing and manufacturing the Invisalign® System, the world’s most advanced clear aligner system, iTero™ intraoral scanners, and exocad™ CAD/CAM software. These innovations enable digital orthodontics and restorative dentistry, improving patient outcomes and practice efficiencies for over 261,000 doctor customers worldwide. Since its establishment, Align Technology has treated over 17.6 million patients with Invisalign, driving the evolution of digital dentistry through the Align Digital Platform™.
The company’s flagship product, the Invisalign System, has revolutionized the approach to orthodontic treatment. Utilized in over 90 countries, Invisalign combines proprietary virtual modeling software and rapid mass-manufacturing processes to develop customized aligners for each patient. It's a preferred choice for treating a wide range of malocclusions, from simple to complex cases. The system has gained the trust of over 230,000 Invisalign-trained dentists and orthodontists globally.
Align Technology also offers the iTero intraoral scanner, which uses advanced parallel confocal imaging technology to capture detailed digital impressions of patients' teeth, facilitating accurate treatment plans and enhancing patient communication. Over 85% of Invisalign cases start with digital scans, underscoring the importance of iTero technology in modern dental practices.
In 2024, the company launched the iTero Lumina™, a next-generation intraoral scanner that offers a 3X wider field of capture with a significantly smaller and lighter wand, providing faster, more accurate scans and superior patient comfort. This innovation exemplifies Align's commitment to continuous improvement and leveraging emerging technologies.
Align’s commitment to innovation is further demonstrated by its recent acquisition of Cubicure GmbH, a pioneer in direct 3D printing solutions. This acquisition strengthens Align’s strategic innovation roadmap and enhances its manufacturing capabilities for 3D printed products such as the Invisalign Palatal Expander System. This new system offers a removable, clinically effective alternative to traditional palatal expanders, further solidifying Align’s position at the forefront of digital orthodontics.
The company’s financial health remains robust, with significant investments in R&D aimed at driving future growth. Align continues to support clinical and scientific research worldwide through its annual Research Awards Program, fostering advancements in dental care.
Align Technology maintains a strong market presence, bolstered by strategic partnerships and a broad product portfolio, ensuring its role as a leader in the rapidly evolving dental industry. For more information, visit www.aligntech.com.
Align Technology announced a multi-year partnership with the New Orleans Saints, designating Invisalign as the 'Official Smile' partner. This collaboration aims to boost awareness and demand for Invisalign treatments through social and digital platforms. The partnership includes promoting defensive end Cam Jordan's Invisalign experience, benefiting the Youth Empowerment Project (YEP) in providing makeover treatments to underserved youth. Align has treated over 8 million patients with Invisalign, focusing on transforming smiles and enhancing community engagement.
Align Technology launched the Align Digital and Practice Transformation (ADAPT) service to aid orthodontic practices in transitioning to digital workflows. This fee-based consulting service aims to optimize operational processes, enhancing patient experiences and overall practice efficiency.
Practices involved in the pilot saw an average revenue increase of 20% and a 15% profit rise within six months of ADAPT implementation. The service will be globally available across the EMEA, APAC regions, and the US in late 2020.
Align Technology reported Q2 2020 total revenues of $352.3 million, down 41.3% year-over-year. The GAAP net loss per diluted share was $(0.52), and non-GAAP net loss was $(0.35). Invisalign volume fell to 221.9 thousand cases, a 41.2% decrease. The company acquired exocad for $430 million, aiming to enhance its digital platform. Although practices are reopening, uncertainty around the pandemic's impact persists, leading to no guidance for Q3 2020.
Align Technology (Nasdaq: ALGN) announced the awarding of nine research grants as part of its Annual Research Award Program, reflecting growing global interest in dental and orthodontic treatments. The grants support various orthodontic research projects, validating the efficacy of the Invisalign system in clinical applications. Award recipients include institutions from North America, Europe, and Asia Pacific, addressing topics such as the effects of orthodontic appliances and treatment methodologies.
Align Technology will announce its second quarter 2020 financial results on July 22, 2020, after market close. The results will be available at 4:00 p.m. ET on their Investor Relations website. A conference call will follow at 4:30 p.m. ET to discuss the results. Investors can listen to the call live online and participate via phone. An archived audio webcast and telephonic replay will be available after the call. Align Technology is known for its Invisalign system and digital dental solutions, having treated over 8 million patients.
Align Technology has partnered with MedTech Innovator to support innovative medtech startups in the Asia Pacific region. The collaboration aims to mentor early to mid-stage companies selected for the 2020 Asia Pacific Showcase program. This initiative will award over $300,000 in prizes and support to promote advancements in patient care. Align’s commitment reflects its ongoing dedication to transforming orthodontic and restorative treatments through innovation.
Align Technology, Inc. (Nasdaq: ALGN) will present at two upcoming virtual financial conferences. The first is the Goldman Sachs 41st Annual Healthcare Conference on June 11, 2020, from 2:10 PM to 2:50 PM Eastern Time. The second is the Nasdaq 42nd London Investor Conference on June 17, 2020, from 1:00 PM to 1:50 PM BST. Both presentations can be accessed live via Align's Investor Relations website, with replays available for three months.
Align Technology has launched ClinCheck Pro 6.0, a cloud-based digital treatment planning software for Invisalign. This innovative software allows orthodontists to access treatment tools from any device, enhancing the patient experience through the new 'In-Face' Visualization feature. This feature merges photos of patients' faces with their 3D treatment plans, helping patients visualize their potential new smiles. ClinCheck Pro 6.0 promises easier doctor modifications and a more intuitive user experience. The software will be available starting in Q3 2020.
Align Technology (Nasdaq: ALGN) announced its participation in two upcoming virtual financial conferences. The UBS Global Healthcare Conference is scheduled for May 18, 2020, from 8:20 AM to 9:00 AM Eastern Time, featuring CFO John Morici. The Stifel Healthcare Conference will take place on May 27, 2020, from 1:50 PM to 2:20 PM Eastern Time, with CEO Joe Hogan and CFO John Morici as speakers. Live webcasts will be available on the company's investor relations website, with replays accessible for three months.
Align Technology, Inc. (NASDAQ: ALGN) has announced a change to its 2020 Annual Meeting of Stockholders due to the COVID-19 pandemic. The meeting will now take place on May 20, 2020, at 1:00 p.m. PDT, in a virtual-only format, changing from the previously scheduled time of 10:00 a.m. PDT. Stockholders as of March 25, 2020, can participate virtually and are encouraged to vote in advance using the previously distributed proxy card. A notification regarding this change will be filed with the SEC.
FAQ
What is the current stock price of Align Technology (ALGN)?
What is the market cap of Align Technology (ALGN)?
What is Align Technology's main product?
How many patients have been treated with Invisalign?
What technologies does Align Technology offer?
What is the iTero Lumina™ scanner?
What was the purpose of acquiring Cubicure GmbH?
How does Align Technology support scientific research?
What is the Align Digital Platform?
How many Invisalign-trained doctors are there globally?
What is the financial outlook for Align Technology?
Where can I find more information about Align Technology’s products?
